CELLTECH CHIROSCIENCE

Celltech Chiroscience is a british-based biotech company, founded by Christopher Evans.

#SimilarOrganizations #People #More

CELLTECH CHIROSCIENCE

Industry:
Biotechnology Health Care Life Science

Status:
Active

Technology used in webpage:
Amazon Amazon Virginia Region


Similar Organizations

aumgene-biosciences-logo

Aumgene Biosciences

Aumgene Biosciences is a research driven biotech company.

Current Employees Featured

stephen-shuttleworth_image

Stephen Shuttleworth
Stephen Shuttleworth R&D Management @ Celltech Chiroscience
R&D Management

More informations about "Celltech Chiroscience"

Biotechs Celltech, Chiroscience to merge - MarketWatch

LONDON (CBS.MW) -- With biotech specialists calling it a "defining moment", Europe's biotechnology industry got a big surprise Tuesday as two well-known British biotechs, Celltech โ€ฆSee details»

Chiroscience - Wikipedia

Chiroscience was born from the demise of the company Enzymatix, which was ultimately acquired by Genzyme, when Andrew Richards joined the company and convinced Evans and Peter Keen to launch Chiros, which name was quickly revised to Chrioscience. Seed funding for the company of £3 million was provided by Schroder Ventures, Apax and 3i. Chiroscience became one of the first biotechnology Initial Public Offerings in the United Kingdom in 1994. See details»

Celltech Chiroscience - Crunchbase Company Profile & Funding

Celltech Chiroscience is a british-based biotech company, founded by Christopher Evans. Private; 3,300,900; HighlightsSee details»

Celltech, Chiroscience To Merge; $1B Takeover Creates U.K. Giant

Jun 15, 1999 This values each Chiroscience share at 293 pence, and Chiroscience¿s issued share capital at about #331 million (US$527 million), based on Celltech¿s share price of โ€ฆSee details»

Celltech and Chiroscience merge to create European โ€ฆ

Jun 15, 1999 The deal, creating Celltech Chiroscience plc, will be made on the basis of 62 new Celltech shares for every 100 Chiroscience shares, giving the former's stockholders a 52.4% โ€ฆSee details»

Celltech merges with struggling Medeva to create £1.3bn group

Nov 12, 1999 CELLTECH CHIROSCIENCE, the biopharmaceutical company, yesterday pulled off its second takeover in five months with an agreed £563m bid for Medeva, the struggling โ€ฆSee details»

Celltech - Wikipedia

Celltech Group plc was a leading British-based biotechnology business based in Slough. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index . Celltech โ€ฆSee details»

BBC News | The Company File | Celltech and Medeva โ€ฆ

Nov 15, 1999 Two of the UK's leading biotechnology companies, Celltech Chiroscience and Medeva, have announced a £1.3bn merger to create a new internationally orientated group. Celltech Chiroscience will buy Medeva for โ€ฆSee details»

CELLTECH GROUP LIMITED overview - Find and update company โ€ฆ

CELLTECH GROUP LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business โ€ฆSee details»

Celltech to merge with Chiroscience | C&EN Global Enterprise

Jun 21, 1999 Two drug discovery companies based in the U.K.โ€”Celltech and Chiroscience Groupโ€”are merging to create one of the largest biopharmaceutical firms in Europe. Each โ€ฆSee details»

Celltech and Chiroscience in pounds 700m biotech merger

Jun 15, 1999 Based on Celltech's closing price of 472.5p and market capitalisation of pounds 365m, the deal values Chiroscience at pounds 331m, or 293p per share, an 18.3 per cent โ€ฆSee details»

Celltech and Medeva to merge - This is Money

Nov 11, 1999 Celltech Chiroscience would offer 34 new shares for every 100 Medeva shares held in an all-paper deal that values each Medeva share at 165 p and the whole of Medeva at โ€ฆSee details»

Celltech, Chiroscience fire merger gun - Nature Biotechnology

The Celltech-Chiroscience deal may be the "starting gun" that awakens the boards of biotechnology companies seriously and urgently to consider merger options. "Everyone is now โ€ฆSee details»

£700m merger in biotech sector - This is Money

Jun 15, 1999 Chiroscience shareholders will own 47.6% of the new company and stakeholders in Celltech with have 52.4%. Chiroscience chief executive Dr John Pad-field has resigned and โ€ฆSee details»

Celltech Chiroscience Plc - Drug pipelines, Patents, Clinical trials ...

Explore Celltech Chiroscience Plc with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»

Celltech Chiroscience - Drug pipelines, Patents, Clinical trials

Explore Celltech Chiroscience with its drug pipeline, therapeutic area, technology platform, 1 literature. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last โ€ฆSee details»

Chiroscience Group - Ownership and Business Overview - Mergr

Chiroscience Group plc (United Kingdom) 283 Cambridge Science Park, Cambridge, CB4 4WE United Kingdom, 44 1223 420430See details»

Celltech to quit Chirotech for pounds 59m - The Independent

Sep 29, 1999 CELLTECH CHIROSCIENCE, the UK's leading biotechnology technology, is to exit compound manufacturing, after Ascot, a diversified holding company, exercised an option โ€ฆSee details»

Celltech Unveils Friendly Bid to Buy Chiroscience Group for $527.7 ...

Jun 16, 1999 Celltech PLC proposed a 331 million pound ($527.7 million or 506.3 million euro) acquisition of Chiroscience Group PLC, opening a huge gap to rival biotechnology companies โ€ฆSee details»

Celltech Chiroscience - Contacts, Employees, Board Members

Celltech Chiroscience is a british-based biotech company, founded by Christopher Evans.See details»

linkstock.net © 2022. All rights reserved